Professor Andy Lewis presents at PODD 2024 in Boston
We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily. Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …
Why Intravaginal Drug Delivery Is the Future of Women’s Health
When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …
Pitching at the Merck Innovation Challenge
What a privilege it was for Lara and I to present Calla Lily Clinical Care to senior members of Merck Group and M Ventures . Selected out of 100+ women’s health startups from around the world, we were able to share our vision for our transformational Callavid drug delivery platform, beginning with pregnancy & fertility. …
Pitching at the Merck Innovation Challenge
Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …
Callavid to be featured at PODD Conference
Excited to announce that Calla Lily Clinical Care will be attending the PODD Conference in Boston next week! Our Principal Scientist Andrew Lewis and co-founder Lara Zibners will be showcasing our innovative vaginal drug delivery platform and its numerous applications beginning with pregnancy and fertility, and exploring new partnership opportunities. Stay tuned for updates on …
Returning to Stanford University / Stanford d.school
I’m thrilled to be heading back to Stanford University and The Stanford d.school for the first time since graduating! I’ll be in the Bay Area next week from October 21st, representing Calla Lily Clinical Care 🌸. I’m excited to reconnect with professors, industry leaders, and former collegues on our exciting Callavid and Phlovid progress. I’d …
Top 6 Takeaways from the Women’s Health Innovation Summit in Boston
I feel like Boston is the place to be these days! I made my 3rd trip there in the last year to attend the Women’s Health Innovation Summit in Boston thanks to Kisaco Research and it was inspiring, to say the least. The event assembled leaders, innovators, and passionate professionals all focused on one mission: …
Calla Lily at CPHI Milan
We had an exciting & intense three days at CPHI Milan, connecting with business leaders from across the global life sciences industry, especially those passionate about advancing Womens Health. It was a pleasure to meet with our existing partners in person and explore exciting new materials and suppliers. We also uncovered unique opportunities for collaboration …
Visit to MIT Center for Gynepathology Research
I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …
Attending Tommy’s Preterm Birth Policy Lab
It has been an absolute pleasure and privilege participating at the Tommy’s Preterm Birth Policy Lab today hosted by Prof Catherine Williamson and Prof Anna David, moderated by Ross Pow (perfectly on schedule!). Experts from so many disciplines expressed their hopes and highlighted the obstacles on the road towards a real change in preventing PTB. …